Skip to content

Progression of refractive error in myopic Chinese children wearing commercially-available single vision spectacles

Myopia progression with single vision spectacles

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-10000914
Enrollment
Unknown
Registered
2010-06-27
Start date
2010-07-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopia

Interventions

1:Commercially-available,spherical-profile spectacle lenses to be worn all waking hours.
2:Commercially-available aspheric front surface spectacle lenses to be worn all waking hours.

Sponsors

Zhongshan Ophthalmic Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
7 Years to 14 Years

Inclusion criteria

Inclusion criteria: 1. Have a parent or guardian who is able to read and comprehend Mandarin and who gives informed consent as demonstrated by signing a record of Informed Consent by parent / guardian, and the subject if able to give their own consent; 2. Be ethnic Chinese, male or female, 7 to 14 years of age inclusive; 3. Be myopic (short-sighted) -0.50 D minimum spherical component to -3.50 D spherical equivalent, with astigmatism no more than 0.75 D; 4. Be willing to comply with the wearing and clinical trial visit schedule as directed by the Investigator; 5. Be willing to wear only the spectacles provided by the Investigators; 6. Have ocular health findings considered to be “normal”;7. Have best correctable vision of at least 6/9.5 in each eye.

Exclusion criteria

Exclusion criteria: 1. Have a known allergy to, or a history of intolerance to tropicamide or topical anaesthetics; 2. Be anisometropic by more than 1.50 D; 3. Have undergone atropine treatment for myopia control; 4. Have strabismus and/or amblyopia; 5. Have had previous eye surgery (including strabismus surgery); 6. Have any ocular, systemic or other condition or disease with possible associations with myopia or affecting refractive development e.g. Marfan syndrome, retinopathy of prematurity, diabetes; 7. Have had any ocular injury or condition (including keratoconus and herpes keratitis) of the cornea, conjunctiva or eyelids; 8. Have worn bifocal or progressive addition spectacles in the previous 12 months; 9. Have worn orthokeratology contact lenses in the previous 12 months; 10. Current orthoptic treatment or vision training; 11. Have any anatomical, skin or other condition that would impact on the wearing of spectacles; 12. Be currently enrolled in another clinical trial. The Investigator may, at his/her discretion, exclude anyone else who they believe may not be able to fulfil the study requirements, or if it is believed to be in the subject's best interests.

Design outcomes

Secondary

MeasureTime frame
Change in spherical equivalent refraction and axial length from baseline levels lenses in children;

Primary

MeasureTime frame
Change in spherical equivalent refraction and axial length from baseline levels;

Countries

China

Contacts

Public ContactXiang Chen
x.chen@brienholdenvision.org+86 020 87330386

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026